首页> 外文期刊>Journal of Korean Neurosurgical Society >Aneurysmal Rebleeding : Factors Associated with Clinical Outcome in the Rebleeding Patients
【24h】

Aneurysmal Rebleeding : Factors Associated with Clinical Outcome in the Rebleeding Patients

机译:动脉瘤性再出血:再出血患者的临床结果相关因素

获取原文
           

摘要

Objective Aneurysmal rebleeding is a major cause of death and disability. The aim of this study is to investigate the incidence of rebleeding, and the factors related with patient's outcome. Methods During a period of 12 years, from September 1995 to August 2007, 492 consecutive patients with aneurysmal subarachnoid hemorrhage (SAH) underwent surgery at our institution. We reviewed the patient's clinical records, radiologic findings, and possible factors inducing rebleeding. Also, we statistically analyzed various factors between favorable outcome group (FG) and unfavorable outcome group (UG) in the rebleeding patients. Results Rebleeding occurred in 38 (7.7%) of 492 patients. Male gender, location of aneurysm (anterior communicating artery) were statistically significant between rebleeding group and non-rebleeding group ( p = 0.01 and p = 0.04, respectively). Rebleeding occurred in 26 patients (74.3%) within 2 hours from initial attack. There were no statistically significant factors between FG and UG. However, time interval between initial SAH to rebleeding was shorter in the UG compared to FG (FG = 28.71 hrs, UG = 2.9 hrs). Conclusion Rebleeding occurs more frequently in the earlier period after initial SAH. Thus, careful management in the earlier period after SAH and early obliteration of aneurysm will be necessary.
机译:目的动脉瘤再出血是导致死亡和残疾的主要原因。这项研究的目的是调查再出血的发生率以及与患者预后相关的因素。方法从1995年9月至2007年8月的12年中,本院连续进行了492例动脉瘤性蛛网膜下腔出血(SAH)患者的手术。我们复查了患者的临床记录,影像学检查结果以及诱发再出血的可能因素。此外,我们对再出血患者的有利结果组(FG)和不利结果组(UG)之间的各种因素进行了统计分析。结果492例患者中有38例(7.7%)发生了再出血。再出血组和未再出血组之间的男性性别,动脉瘤位置(前交通动脉)在统计学上均具有统计学意义(分别为p = 0.01和p = 0.04)。初次发作后2小时内,有26例患者(74.3%)发生了再出血。 FG和UG之间无统计学意义的因素。但是,与FG相比,UG中初始SAH到再出血之间的时间间隔更短(FG = 28.71 hrs,UG = 2.9 hrs)。结论初次SAH发生后,再出血的发生频率更高。因此,有必要在SAH术后的早期进行仔细的处理,并尽早消除动脉瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号